amantadine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khasanova, DR | 1 |
| Saĭkhunov, MV | 1 |
| Kitaeva, EA | 1 |
| Khafiz'ianova, RKh | 1 |
| Islaamov, RR | 1 |
| Demin, TV | 1 |
1 trial available for amantadine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
[Amantadine sulfate (PK-Merz) in the treatment of ischemic stroke: a clinical-experimental study].
Topics: Aged; Aged, 80 and over; Amantadine; Animals; Blotting, Western; Calcium Channel Blockers; Conscious | 2009 |